Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

MEPACT

A drug being studied in the treatment of young adults with bone cancer that has gotten worse or come back. MEPACT activates certain types of white blood cells and helps the immune system kill cancer cells. It is a type of immunostimulant. Also called L-MTP-PE, mifamurtide, and muramyl tripeptide phosphatidylethanolamine.

MEPACT

Search NCI's Dictionary of Cancer Terms